Skip to main content
. 2022 Feb 17;28(8):1572–1585. doi: 10.1158/1078-0432.CCR-21-3324

Table 3.

All reported SAEs per patient, viral dose, and relation to treatment.

Patient Dose (vp) SAE Grade Relation to treatment
5 108 Neck pain (in combination with fever) 2 Unrelated
6 108 Hydrocephalus 4 Unrelated
7 109 Urinary tract infection 2 Unrelated
7 109 Neurological deterioration 3 Unrelated
7 109 Diverticulitis resulting in sigmoid perforation and sepsis 5 Unrelated
9 109 Confusion 4 Related to Delta24-RGD infusion
10 1010 Seizure (generalized) 3 Related to Delta24-RGD infusion
11 1010 Neurological deterioration 2 Unrelated
12 1010 Chronic subdural hematoma 2 Unrelated
13 3 × 1010 Increased intracranial pressure 3 Related to Delta24-RGD infusion
14 Not infused Neurological deterioration 3 Related to catheter surgery
15 3 × 1010 Meningitis with hydrocephalus 3 Related to Delta24-RGD infusion
16 1010 Wound dehiscence at the site of the Ommaya 3 Related to other study procedure
17 1010 Increased intracranial pressure 3 Related to Delta24-RGD infusion
17 1010 Wound dehiscence at the site of the Ommaya 3 Related to other study procedure
19 1010 Depressed level of consciousness 4 Unrelated
20 1010 Seizure 3 Related to Delta24-RGD infusion